NSE · JUBLPHARMA
Jubilant Pharmova Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#412
of 5,096 stocks
▲ 41W
Peak #412 · 27 Sep 2026
Jubilant Pharmova Limited is a midcap company in the Healthcare space and is growing revenue at a solid clip, commands a premium earnings multiple, and posts a modest return on equity.
Market Cap
16,755.11 Cr
P/E Ratio
42.17
P/B Ratio
2.36
ROE
5.60%
ROCE
6.82%
Dividend Yield
0.47%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 2,229.40 Cr | 2,290.00 Cr | 2,122.50 Cr | 1,966.40 Cr |
| Net Profit | 56.40 Cr | 119.30 Cr | 55.80 Cr | 119.90 Cr |
| EPS | 3.57 | 7.55 | 3.52 | 7.59 |
| Operating Profit | 140.60 Cr | 246.20 Cr | 189.30 Cr | 246.40 Cr |
Shareholding pattern
Promoter
47.68%
Public
51.77%
PUBLIC BREAKDOWN
FII
15.87%
DII
12.40%
MF (within DII)
8.99%
Individuals
18.37%
Mutual fund holdings
₹776.54
Cr total
55
Schemes
21
Fund Houses
₹776.54 Cr
Total Exposure
Quant Mutual Fund₹259.91 Cr (33.5%)
Kotak Mahindra Mutual Fund₹240.24 Cr (30.9%)
Abakkus Mutual Fund₹88.26 Cr (11.4%)
HDFC Mutual Fund₹83.84 Cr (10.8%)
Aditya Birla Sun Life Mutual Fund₹59.00 Cr (7.6%)
Others₹45.28 Cr (5.8%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 24 Jul 2026 | Dividend | Dividend - Rs 5 Per Share |
| 25 Jul 2025 | Dividend | Dividend - Rs 5 Per Share |
| 02 Aug 2024 | Dividend | Dividend - Rs 5 Per Share |
| 10 Aug 2023 | Dividend | Dividend - Rs 5 Per Share |
| 11 Aug 2022 | Dividend | Dividend - Rs 5 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.